Lv2
128 积分 2023-02-20 加入
A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
3天前
已完结
Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis
1个月前
已完结
Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins
4个月前
已完结
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
6个月前
已完结
Knowing the unknowns in high risk multiple myeloma
6个月前
已完结
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population‐based analysis
6个月前
已完结
The genetic architecture of multiple myeloma
6个月前
已完结
Current State of Evidence on Definitions and Management of High-Risk Multiple Myeloma
6个月前
已完结
International Staging System for Multiple Myeloma
6个月前
已完结
Renal insufficiency in multiple myeloma: a systematic review and meta-analysis of all randomized trials from 2005–2019
6个月前
已完结
皖公网安备34019202002308
